EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Fan et al. Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease. Molecules 2022, 27, 7524

Dongxiao Fan, Chenshu Liu, Zhongyu Zhang, Kan Huang, Tengyao Wang, Sifan Chen, Zilun Li

Molecules · 12.10.2024 · 29 (20) · 4840

DOI: 10.3390/molecules29204840 ↗

Kurz gefasst

Korrektur in der Zeitschrift Molecules, online erschienen am 12.10.2024. Verfasst von Dongxiao Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Science and Technology Program Key Projects, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Text Correction [...]

Autor:innen und Institutionen

  • Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
  • National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Chi…
  • Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.

Förderung

  • Guangzhou Science and Technology Program Key Projects
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Guangdong Science and Technology Department

Zitieren

APA

Fan, D., Liu, C., Zhang, Z., Huang, K., Wang, T., Chen, S., & Li, Z. (2024). Correction: Fan et al. Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease. Molecules 2022, 27, 7524. Molecules, 29(20), 4840. https://doi.org/10.3390/molecules29204840

Vancouver

Fan D, Liu C, Zhang Z, Huang K, Wang T, Chen S, et al. Correction: Fan et al. Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease. Molecules 2022, 27, 7524. Molecules. 2024;29(20):4840. doi:10.3390/molecules29204840

BibTeX
@article{Fan2024,
  author = {Fan, Dongxiao and Liu, Chenshu and Zhang, Zhongyu and Huang, Kan and Wang, Tengyao and Chen, Sifan and Li, Zilun},
  title = {Correction: Fan et al. Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease. Molecules 2022, 27, 7524},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {20},
  pages = {4840},
  doi = {10.3390/molecules29204840}
}
Kostenlos starten →